Effectiveness of Photobiomodulation in Reducing Pain of Oral Mucosal Diseases: A Case Series
Astrid Widhowaty Santoso,Irna Sufiawati
DOI: https://doi.org/10.2147/IMCRJ.S414313
2023-07-14
International Medical Case Reports Journal
Abstract:Astrid Widhowaty Santoso, 1 Irna Sufiawati 2 1 Oral Medicine Residency Program, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia; 2 Oral Medicine Department, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia Correspondence: Irna Sufiawati, Oral Medicine Department, Faculty of Dentistry, Universitas Padjadjaran, Jalan Sekeloa Selatan I, Bandung, 40132, Indonesia, Email Introduction: Pain management becomes important in the treatment of oral mucosal diseases since it can impair the quality of life. Photobiomodulation (PBM) as an alternative therapy, has potency in reducing pain through several mechanisms targeting peripheral nerves in the target tissue. Purpose: To discuss the effectiveness of PBM in the management of four cases of oral mucosal diseases. Case: Four patients, two females and two males, with an age ranging from 24 to 63 years came to the Oral Medicine Department complaining of painful lesions in their oral cavity. Three cases showed ulceration of the oral mucosa and had been diagnosed with recurrent aphthous stomatitis, recalcitrant chronic ulcer, and non-specific chronic sialadenitis. One patient who complained of intense pain and swelling on the right side of the face was diagnosed with post-herpetic neuralgia (PHN). Case Management: PBM was administered in all four cases (976 nm diode laser, three cases with spot size 0.01 cm 2 , fluency 10 J/cm 2 , and one case with spot size 0.5 cm 2 ; fluency 3 J/cm 2 ). Visual analog scale (VAS) control was performed before and after the PBM at each visit. The recorded VAS results show a reduction in pain that started at the post-laser time, with VAS before PBM ranging from 5 to 7 and after PBM ranging from 0 to 4. Three patients were given triamcinolone acetonide 0.1%, chlorhexidine gluconate 0.2% mouthwash, petroleum jelly, and multivitamins. One patient was given mefenamic acid and multivitamins. Conclusion: PBM can be a useful adjunctive treatment to relieve the pain of oral mucosal diseases due to its ability to reduce pain intensity. Keywords: low-level laser therapy, oral lesions, pain, photobiomodulation According to the International Association for the Study of Pain (IASP), pain is characterized as an unpleasant sensory and emotional experience due to tissue damage, or has the potential to cause tissue damage or conditions that indicate tissue damage. 1 Pain in the oral and facial region greatly affects the quality of life since it interferes with many essential functions, including decreasing food intake, inability to maintain oral hygiene, and impairing swallowing or speaking, especially if it produces severe pain in both acute and chronic lesions. 2,3 Various pathological conditions in the oral cavity can lead to acute and chronic pain. Ulcerative lesions are the most common cause of pain in the oral mucosa with recurrent aphthous stomatitis (SAR) as the most common ulcerative lesion. 3 Moreover, post-herpetic neuralgia may contribute to conditions associated with neuropathic pain in the oral mucosa (PHN). 4 With this condition, pain management becomes paramount. Various therapeutic approaches are known to reduce pain and accelerate wound healing, including analgesics, corticosteroids, anti-inflammatory drugs, and phytotherapy. 5 However, the use of some of these drugs, such as steroid and non-steroidal anti-inflammatory drugs, is nonetheless limited when given to elderly, pediatric, and patients with impaired kidney and liver function since it contains various side effects. 6 In addition, managing cases of PHN is still considered challenging, and heretofore no treatment is thought to be effective in reducing the incidence of PHN in patients with herpes zoster. 7,8 Biostimulation is thought to be an appropriate alternative therapy for managing pain due to oral ulceration 9 and PHN. 7 Low-level laser therapy (LLLT) or photobiomodulation (PBM) therapy is a non-invasive, drug-free therapy that is widely used as an alternative therapy for oral ulcers. PBM uses light energy to generate biological responses from cells and restore normal cell function, 5,10 hence, it is considered effective in reducing pain intensity, reducing edema and inflammation, as well as accelerating ulcer healing. 5 The mechanism of pain reduction in PBM is related to physiological neural changes such as blockage of action potential generation and conduction of nociceptive signals in primary afferent neurons. In addition, the pain reduction effect also occurs through modulation of the release of inflammatory mediators and alteration in lymphocyte metab -Abstract Truncated-